Immediate Impact
5 by Nobel laureates 35 from Science/Nature 75 standout
Citing Papers
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
2023 Standout
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Works of Rita Chiari being referenced
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
2019
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Rita Chiari | 2582 | 2288 | 1372 | 139 | 4.1k | |
| Daniel S.W. Tan | 1749 | 1803 | 1249 | 156 | 3.8k | |
| Biagio Ricciuti | 2475 | 1588 | 992 | 155 | 3.6k | |
| Noemı́ Reguart | 2763 | 2503 | 2461 | 172 | 5.4k | |
| Noriko Yanagitani | 1879 | 1923 | 1893 | 171 | 4.2k | |
| Jordi Remón | 2056 | 2283 | 959 | 172 | 3.5k | |
| Tao Jiang | 3155 | 2586 | 1676 | 170 | 5.2k | |
| Caicun Zhou | 3534 | 3273 | 1487 | 205 | 5.4k | |
| Antonio Chella | 2849 | 3463 | 1580 | 129 | 5.3k | |
| Wendy A. Cooper | 2455 | 2814 | 1906 | 124 | 5.4k | |
| Jin‐Ji Yang | 3377 | 3800 | 1165 | 143 | 4.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...